ELIZABETH PECK: Open Payments
NPI 1417653791 · EDEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 23 payments from 9 companies in 2025. Trend: 2023 $331 · 2024 $807 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Amgen Inc. | 4 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $43 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: LEQVIO, Kerendia, REPATHA, FARXIGA, VERQUVO, FUROSCIX, Wegovy, JARDIANCE.
Industry payments across NC — which companies pay providers there.
